活体CAR-T疗法-可编程免疫的新时代
Stefano Pierini1, Rehman Qureshi1, Sergei Pustylnikov2
1Independent Researcher, Philadelphia, PA 19342, USA.
International journal of molecular sciences
|February 27, 2026
概括
在体内化学抗原受体 (CAR) T细胞疗法为体外CAR-T提供了一个有前途的替代方案,可能降低成本和生产时间. 本综述探讨了新兴的体内平台及其相关挑战和机遇.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 活体CAR-T细胞疗法已在治疗血液性恶性瘤方面取得成功,但面临制造和成本限制.
- 自2022年以来减少的生物技术投资进一步强调了对更容易获得的细胞疗法的需求.
- 在体内CAR-T方法旨在在患者体内产生CAR-T细胞,解决体外限制.
研究的目的:
- 审查主要和新兴的体内CAR-T交付平台.
- 分析这些平台的技术,性能和发展路径.
- 讨论该领域的科学,技术和生物挑战.
主要方法:
- 审查现有的关于体内CAR-T输送系统的文献.
- 对各种传递平台 (lentiviral,LNPs) 的临床前和临床数据的分析.
- 讨论安全性,疗效和监管方面的考虑.
主要成果:
- 使用晶状病毒或脂质纳米粒子 (LNP) 载体的体内CAR-T策略显示了简化生产和降低成本的潜力.
- 这些方法带来了有关基因组安全,免疫反应和监管监督的新挑战.
- 该领域正在迅速发展,正在研究可编程T细胞免疫力.
结论:
- 活体CAR-T细胞生成是一个显著的进步,有可能扩大对CAR-T疗法的获取.
- 解决安全性,特异性和监管障碍对于临床翻译至关重要.
- 对交付平台和生物挑战的进一步研究将塑造体内CAR-T治疗的未来.
相关概念视频
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Gene Therapy
27.8K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.8K
Microorganisms in Medicine and Therapeutics
1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
Cytotoxic T Cells-mediated Immune Response
7.7K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.7K
Cancer Vaccines
1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Cell-mediated Immune Responses
85.0K
Overview
85.0K


